Panlin Capital, based in China, has closed its twelfth primary fund. The Chengdu Panlin Xiangxu Fund’s limited partners are Luzhou Laojiao, Eurocrane, CICC Genesis, Chengdu Science Service Group, and the Chengdu Productivity Promotion Centre.
The size of the fund was not disclosed by the firm. Tech in Asia has contacted Panlin Capital for more information.
Li Yuhui, Tan Huidong, and Yuheng Liu established Panlin Capital in 2010, with its main office in Shanghai. According to the Forbes China Top 100 Venture Capitalists list’s website, Li has been listed there for the previous six years.
The Chengdu Panlin Xiangxu Fund seeks to invest in “To B” companies, which include software, intelligent equipment, industrial aggregation platforms, and “hard technology” businesses that seek to modernize and transform China’s industrial endeavors. Startups like O-cubes, Chipanalog, and Ruiyun Cold Chain have already benefited from investments made by the fund.
Additionally, Panlin Capital makes investments in healthcare businesses, particularly those operating in the biotechnology and artificial intelligence sectors. With a first close of 1 billion yuan (US $140 million) in 2021, Panlin’s most recent flagship private equity fund focused on the healthcare sector.
